Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
146.15
-5.43 (-3.58%)
At close: Oct 30, 2026, 4:00 PM EDT
148.00
+1.85 (1.27%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Palvella Therapeutics Employees
Palvella Therapeutics had 29 employees as of December 31, 2025. The number of employees increased by 15 or 107.14% compared to the previous year. That makes Palvella Therapeutics the 37,234th largest employer in the world and 5,200th in the United States.
Employees
29
Change (1Y)
15
Growth (1Y)
107.14%
Revenue / Employee
n/a
Profits / Employee
-$2,127,448
Market Cap
2.11B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 29 | 15 | 107.14% |
| Dec 31, 2024 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Maravai LifeSciences Holdings | 415 |
| Vericel | 398 |
| Vir Biotechnology | 367 |
| Immunome | 247 |
| Zymeworks | 231 |
| Lakefront Biotherapeutics NV | 196 |
| Absci | 140 |
PVLA News
- 1 day ago - Palvella Therapeutics price target lowered to $232 from $240 at Mizuho - TheFly
- 1 day ago - Palvella Therapeutics to Host Third Quarter 2026 Financial Results and Corporate Update Conference Call on November 5, 2026 - GlobeNewsWire
- 2 days ago - Palvella Therapeutics announces FDA acceptance, priority review for Qtorin NDA - TheFly
- 2 days ago - Palvella Announces FDA Acceptance and Priority Review of QTORIN™ Rapamycin NDA; February 28, 2027 PDUFA Target Action Date Set - GlobeNewsWire
- 10 days ago - Clear Street sees positive read for Palvella from FDA rare disease framework - TheFly
- 10 days ago - Palvella Therapeutics Transcript: Chardan's 10th Annual Healthcare Conference - Transcripts
- 14 days ago - Raymond James says new data supportive of broad label for Qtorin - TheFly
- 15 days ago - Palvella Therapeutics initiated with an Outperform at William Blair - TheFly